Bml-210

Bml-210

• Background: A novel non-hydroxamic acid HDAC inhibitor. IC50=5-10 µM (HeLa nuclear extract). Induces growth inhibition, proapoptotic and differentiation effects on human leukemia cell lines.
• Description: HDAC inhibitor
• Alternative Name: N1-(2-aminophenyl)-N8-phenyloctanediamide
• CAS Number: 537034-17-6
• UNSPSC: 41116105
• Source: Synthetic
• Purity: >98% (TLC), NMR conforms
• Weight: 0.025
• Format: Tan Solid
• Solubility: Soluble in 25 mg/ml DMSO or 10 mg/ml Ethanol
• Molecular Formula: C20H25N3O2
• Molecular Weight: 339.4
• Precautions: Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
• References & Citations: 1. Savickiene J., et al. (2006) Eur. J. Pharmacol. 549: 9. 2. Herman D., et al. (2006) Nature Chem. Biol. 10: 551.